Detalhe da pesquisa
1.
Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma.
bioRxiv
; 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293232
2.
A novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancer.
Cancer Biol Ther
; 24(1): 2202104, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37069726
3.
ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancer.
Am J Cancer Res
; 12(2): 521-536, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35261784
4.
Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer.
Am J Cancer Res
; 11(11): 5374-5387, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34873466
5.
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
J Exp Clin Cancer Res
; 40(1): 61, 2021 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33557912
6.
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy.
Neoplasia
; 22(12): 725-744, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33142238